AC IMMUNE SA REPORTS FIRST QUARTER 2017 FINANCIAL RESULTS
May 11, 2017 10:15 am UTC| Business
Strong cash position of CHF 138.1 million provides resources to advance pipeline of seven therapeutic and three diagnostic candidates Second pivotal Phase 3 clinical trial of crenezumab - CREAD 2 - started by partner...
AC IMMUNE SA REPORTS FIRST QUARTER 2017 FINANCIAL RESULTS
May 11, 2017 10:15 am UTC| Business
Strong cash position of CHF 138.1 million provides resources to advance pipeline of seven therapeutic and three diagnostic candidates Second pivotal Phase 3 clinical trial of crenezumab - CREAD 2 - started by partner...
AC IMMUNE SA REPORTS FIRST QUARTER 2017 FINANCIAL RESULTS
May 11, 2017 10:15 am UTC| Business
Strong cash position of CHF 138.1 million provides resources to advance pipeline of seven therapeutic and three diagnostic candidates Second pivotal Phase 3 clinical trial of crenezumab - CREAD 2 - started by partner...
Smart Sand, Inc. Announces First Quarter 2017 Results
May 11, 2017 09:45 am UTC| Business
Revenues of $25.0 million Tons sold totaled approximately 558,500, an increase of 103% sequentiallyNet Income of $1.0 million, or $0.02 per basic and diluted share Adjusted EBITDA of $3.7 million THE WOODLANDS, Texas,...
Environmental Gas Sensors Market 2017-2027
May 11, 2017 09:35 am UTC| Business
Dublin, May 11, 2017 -- Research and Markets has announced the addition of the "Environmental Gas Sensors 2017-2027" report to their offering. This report covers the broad range of...
Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2017
May 11, 2017 09:31 am UTC| Business
DUBLIN, Ireland, May 11, 2017 -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and nine month periods ended March 31, 2017. Recent highlights: In April 2017, entered into a...
Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2017
May 11, 2017 09:31 am UTC| Business
DUBLIN, Ireland, May 11, 2017 -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and nine month periods ended March 31, 2017. Recent highlights: In April 2017, entered into a...